Financial statements Hemp Pharm
Balance sheet data of HEMP PHARM
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 189 859,71 | 175 211,79 | 144 184,44 | 109 598,15 |
| A. Fixed assets | 95 944,60 | 81 400,27 | 66 855,94 | 52 671,61 |
| B. Current assets | 93 915,11 | 93 811,52 | 77 328,50 | 56 926,54 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 189 859,71 | 175 211,79 | 144 184,44 | 109 598,15 |
| A. Equity | 186 365,33 | 149 162,22 | 117 147,38 | 89 341,97 |
| B. Liabilities and provisions for liabilities | 3 494,38 | 26 049,57 | 27 037,06 | 20 256,18 |
| I. Long-term liabilities | - | - | - | - |
| II. Short-term liabilities | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.